Literature DB >> 14992570

Syndromic classification of hereditary lymphedema.

K A Northup1, M H Witte, C L Witte.   

Abstract

Since the late 1800's, the familial occurrence of peripheral lymphedema has been well-documented in Milroy and Meige syndromes. However, the presence of lymphedema in many other hereditary dysmorphic syndromes has not been fully appreciated. In order to establish more standardized and detailed clinical phenotypic criteria as the basis for rational classification and for greater precision in screening and genetic linkage studies, we conducted a comprehensive literature search and review of OMIM-identified and non-identified hereditary syndromes in which lymphedema was reported as a feature. Modes of inheritance, associated clinical features and images, and specific organ involvement were inventoried and suggested pathophysiologic mechanisms noted. The findings support the recommendation that when peripheral lymphedema of undetermined etiology is found, further careful, comprehensive clinical, including detailed dysmorphic, evaluation along with lymphatic imaging with subsequent syndromic classification is warranted. This information can provide clues to underlying pathogenesis and form the basis for genetic counseling and prognostication as well as offer guidance to the clinical investigator translating research at the molecular level into new approaches for evaluation and therapy.

Entities:  

Mesh:

Year:  2003        PMID: 14992570

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  11 in total

Review 1.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

2.  Combining Foxc2 and Connexin37 deletions in mice leads to severe defects in lymphatic vascular growth and remodeling.

Authors:  John D Kanady; Stephanie J Munger; Marlys H Witte; Alexander M Simon
Journal:  Dev Biol       Date:  2015-06-14       Impact factor: 3.582

3.  Heterozygous Mutation of Vegfr3 Reduces Renal Lymphatics without Renal Dysfunction.

Authors:  Hao Liu; Chitkale Hiremath; Quinten Patterson; Saumya Vora; Zhiguo Shang; Andrew R Jamieson; Reto Fiolka; Kevin M Dean; Michael T Dellinger; Denise K Marciano
Journal:  J Am Soc Nephrol       Date:  2021-09-22       Impact factor: 14.978

Review 4.  [Lymphedema: anatomy, physiology and pathophysiology of lymphedema, definition and classification of lymphedema and lymphatic vascular malformations].

Authors:  Walter Döller
Journal:  Wien Med Wochenschr       Date:  2013-04-18

Review 5.  Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia.

Authors:  Marlys H Witte; Michael T Dellinger; Cristobal M Papendieck; Francesco Boccardo
Journal:  Clin Exp Metastasis       Date:  2012-07-15       Impact factor: 5.150

Review 6.  Ocular lymphatics: state-of-the-art review.

Authors:  L Chen
Journal:  Lymphology       Date:  2009-06       Impact factor: 1.286

7.  The godoy & godoy cervical stimulation technique in the treatment of primary congenital lymphedema.

Authors:  José Maria Pereira de Godoy; Ana Carolina Pereira de Godoy; Tânia Dias Guimarães; Maria de Fátima Guerreiro de Godoy
Journal:  Pediatr Rep       Date:  2012-10-02

Review 8.  Congenital pulmonary lymphangiectasia.

Authors:  Carlo Bellini; Francesco Boccardo; Corradino Campisi; Eugenio Bonioli
Journal:  Orphanet J Rare Dis       Date:  2006-10-30       Impact factor: 4.123

9.  Elevated expression of VEGFR-3 in lymphatic endothelial cells from lymphangiomas.

Authors:  Susanne Norgall; Maria Papoutsi; Jochen Rössler; Lothar Schweigerer; Jörg Wilting; Herbert A Weich
Journal:  BMC Cancer       Date:  2007-06-21       Impact factor: 4.430

10.  Four generations of rare familial lymphedema (Milroy disease).

Authors:  Sankalp Gokhale; Sanjay Gokhale
Journal:  Med Princ Pract       Date:  2013-06-04       Impact factor: 1.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.